Ira Dyme
Neurology with Special Qualifications in Child Neurology · East Lansing, MINPI 1275604407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by UCB, Inc. at 24.8% of the total. 2024 is the largest year on record at $617, 2.6 times the $241 reported in 2019.
Across 60 payments — averaging $33.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$507
- Neurelis, Inc.$276
- Neuropace, Inc.$169
- Jazz Pharmaceuticals Inc.$129
- Livanova USA, Inc.$105
- Aquestive Therapeutics, Inc.$103
- plus $750 from 21 others
What the payments were for
- Food & beverage$2,02599%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 15 | $507 |
| Neurelis, Inc. | 6 | $276 |
| Neuropace, Inc. | 2 | $169 |
| Jazz Pharmaceuticals Inc. | 4 | $129 |
| Livanova USA, Inc. | 2 | $105 |
| Aquestive Therapeutics, Inc. | 1 | $103 |
| Eisai Inc. | 1 | $92 |
| Pyros Pharmaceuticals, Inc. | 2 | $58 |
| SK Life Science, Inc. | 2 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Biogen | 2 | $46 |
| Genentech USA, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Argenx US, Inc. | 1 | $34 |
| AbbVie(2 entities) | 2 | $34 |
| Catalyst Pharmaceuticals, Inc. | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Tanabe Pharma America, Inc. | 1 | $28 |
| Greenwich Biosciences, Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Acorda Therapeutics, Inc | 1 | $23 |
| AstraZeneca | 1 | $22 |
| TG Therapeutics, Inc. | 1 | $21 |
| Boston Scientific | 1 | $19 |
| Aucta Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPAZAN$103
- RNS Neurostimulator Kit$101
How this compares
$2,039 in reported general payments places this provider in the 70th percentile of 62 neurology with special qualifications in child neurology providers in Michigan.
See all neurology with special qualifications in child neurology providers in Michigan →
Other neurology with special qualifications in child neurology in East Lansing
- Suad KhalilEast Lansing$146K
- Hiba ElaasarEast Lansing$3K
- Kabelo ThusangEast Lansing$633
- Gyula AcsadiDetroit$86K
- Daniel ArndtWest Bloomfield$62K
- Michelle FigueroaDetroit$57K
- Christopher AllenSaginaw$38K
- Kheir Al-ZouhayliTroy$32K
- Jena KruegerGrand Rapids$22K
- Seth DevriesGrand Rapids$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.